Lindbrook Capital, LLC - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 145 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q4 2021$21,000
+10.5%
610
+18.9%
0.00%
-40.0%
Q3 2021$19,000
-5.0%
5130.0%0.01%
+25.0%
Q2 2021$20,000
+17.6%
513
-14.6%
0.00%0.0%
Q1 2021$17,000
-10.5%
6010.0%0.00%
-20.0%
Q4 2020$19,0000.0%601
+0.8%
0.01%0.0%
Q3 2020$19,000
+18.8%
596
+2.9%
0.01%0.0%
Q2 2020$16,000
+128.6%
579
+44.4%
0.01%
+66.7%
Q1 2020$7,0004010.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders